In addition, activation of peroxisome proliferator-activated receptor-γ by thiazolidinediones significantly improves insulin sensitivity in type 2 diabetic patients (Nolan et al., 1994, Frias et al., 2000). This evidence concerns the gene INS and type 2 diabetes mellitus.